The bill amends Minnesota Statutes 2024, section 148.56, subdivision 1, to modify the limitations on optometrists regarding the prescribing and administering of drugs. It clarifies that optometrists can prescribe or administer legend drugs for the diagnosis and treatment of eye-related conditions, as long as these practices are in accordance with the curricula of accredited optometry schools and the regulations set by the Board of Optometry. Notably, the bill allows for the administration of drugs via sub-Tenon, retrobulbar, or intravitreal injection, which was previously restricted to only treatment of anaphylaxis.

Additionally, the bill introduces new limitations on the prescribing of certain medications. It removes the previous restrictions on the administration of intravenous and intramuscular drugs, while still prohibiting invasive surgeries and the prescription of Schedule II and III oral legend drugs. Furthermore, it specifies that steroids can only be prescribed for a maximum of 14 days without physician consultation, and it eliminates the previous limit on the duration for which oral carbonic anhydrase inhibitors could be prescribed. Overall, the bill aims to expand the scope of practice for optometrists while ensuring patient safety through regulated prescribing practices.

Statutes affected:
Introduction: 148.56